Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score
Ju Dong Yang, Benyam D. Addissie, Kristin C. Mara, et al.
Cancer Epidemiology Biomarkers & Prevention (2018) Vol. 28, Iss. 3, pp. 531-538
Open Access | Times Cited: 169

Showing 1-25 of 169 citing articles:

A global view of hepatocellular carcinoma: trends, risk, prevention and management
Ju Dong Yang, Pierre Hainaut, Gregory J. Gores, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 10, pp. 589-604
Open Access | Times Cited: 3437
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
Al B. Benson, Michael I. D’Angelica, Daniel E. Abbott, et al.
Journal of the National Comprehensive Cancer Network (2021) Vol. 19, Iss. 5, pp. 541-565
Open Access | Times Cited: 735
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Federico Piñero, Melisa Dirchwolf, Mário G. Pessôa
Cells (2020) Vol. 9, Iss. 6, pp. 1370-1370
Open Access | Times Cited: 404
Advances in the early diagnosis of hepatocellular carcinoma
Weiyi Wang, Chao Wei
Genes & Diseases (2020) Vol. 7, Iss. 3, pp. 308-319
Open Access | Times Cited: 343
Management of Hepatocellular Carcinoma
Zachary J. Brown, Diamantis I. Tsilimigras, Samantha M. Ruff, et al.
JAMA Surgery (2023) Vol. 158, Iss. 4, pp. 410-410
Closed Access | Times Cited: 341
New advances in the diagnosis and management of hepatocellular carcinoma
Ju Dong Yang, Julie K. Heimbach
BMJ (2020), pp. m3544-m3544
Open Access | Times Cited: 336
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis
Jan Best, Lars P. Bechmann, Jan‐Peter Sowa, et al.
Clinical Gastroenterology and Hepatology (2019) Vol. 18, Iss. 3, pp. 728-735.e4
Open Access | Times Cited: 226
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
Philip J. Johnson, Qing Zhou, Doan Y Dao, et al.
Nature Reviews Gastroenterology & Hepatology (2022) Vol. 19, Iss. 10, pp. 670-681
Closed Access | Times Cited: 208
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
Amit G. Singal, Nabihah Tayob, Anand S. Mehta, et al.
Hepatology (2021) Vol. 75, Iss. 3, pp. 541-549
Open Access | Times Cited: 122
Validation of a Novel Multitarget Blood Test Shows High Sensitivity to Detect Early Stage Hepatocellular Carcinoma
Naga Chalasani, Kyle Porter, Abhik Bhattacharya, et al.
Clinical Gastroenterology and Hepatology (2021) Vol. 20, Iss. 1, pp. 173-182.e7
Closed Access | Times Cited: 114
Hepatocellular Carcinoma in 2021: An Exhaustive Update
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 104
MASLD and the Development of HCC: Pathogenesis and Therapeutic Challenges
Anju Phoolchund, Salim I. Khakoo
Cancers (2024) Vol. 16, Iss. 2, pp. 259-259
Open Access | Times Cited: 32
Alpha-fetoprotein: Past, present, and future
Yee Hui Yeo, Yi‐Te Lee, Hsian‐Rong Tseng, et al.
Hepatology Communications (2024) Vol. 8, Iss. 5
Open Access | Times Cited: 22
HCC surveillance after SVR in patients with F3/F4 fibrosis
George N. Ioannou
Journal of Hepatology (2020) Vol. 74, Iss. 2, pp. 458-465
Open Access | Times Cited: 135
A multi‐analyte cell‐free DNA–based blood test for early detection of hepatocellular carcinoma
Nan Lin, Yongping Lin, Jianfeng Xu, et al.
Hepatology Communications (2022) Vol. 6, Iss. 7, pp. 1753-1763
Open Access | Times Cited: 69
Serum Biomarkers for the Prediction of Hepatocellular Carcinoma
José D. Debes, Pablo A. Romagnoli, Jhon Prieto, et al.
Cancers (2021) Vol. 13, Iss. 7, pp. 1681-1681
Open Access | Times Cited: 63
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of hepatocellular carcinoma
Tim F. Greten, Ghassan K. Abou‐Alfa, Ann‐Lii Cheng, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 9, pp. e002794-e002794
Open Access | Times Cited: 63
Risk stratification and early detection biomarkers for precision HCC screening
Yi‐Te Lee, Naoto Fujiwara, Ju Dong Yang, et al.
Hepatology (2022), pp. n/a-n/a
Open Access | Times Cited: 60
HCC EV ECG score: An extracellular vesicle‐based protein assay for detection of early‐stage hepatocellular carcinoma
Na Sun, Ceng Zhang, Yi‐Te Lee, et al.
Hepatology (2022) Vol. 77, Iss. 3, pp. 774-788
Open Access | Times Cited: 58
The altered serum lipidome and its diagnostic potential for Non-Alcoholic Fatty Liver (NAFL)-associated hepatocellular carcinoma
Monika Lewińska, Álvaro Santos‐Laso, Enara Arretxe, et al.
EBioMedicine (2021) Vol. 73, pp. 103661-103661
Open Access | Times Cited: 57
The National Consensus statement on the management of adult patients with non-alcoholic fatty liver disease and main comorbidities
M. V. Maevskaya, Yu. V. Kotovskaya, В. Т. Ивашкин, et al.
Terapevticheskii arkhiv (2022) Vol. 94, Iss. 2, pp. 216-253
Open Access | Times Cited: 40
Hepatocellular carcinoma surveillance: current practice and future directions
Joseph Ahn, Yi‐Te Lee, Vatche G. Agopian, et al.
Hepatoma Research (2022)
Open Access | Times Cited: 40
Development of hepatocellular carcinoma in treated and untreated patients with chronic hepatitis B virus infection
Chih‐Lin Lin, Jia‐Horng Kao
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 605-622
Open Access | Times Cited: 40
Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review
Endrit Shahini, Giuseppe Pasculli, Antonio Giovanni Solimando, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4286-4286
Open Access | Times Cited: 29
The Performance of GALAD Score for Diagnosing Hepatocellular Carcinoma in Patients with Chronic Liver Diseases: A Systematic Review and Meta-Analysis
Ming‐Cheng Guan, Shiyu Zhang, Qian Ding, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 949-949
Open Access | Times Cited: 28
Page 1 - Next Page

Scroll to top